Agreed on enrollment. At 50%, NP blamed it on the sites having to pull the data together, but that doesn't make much sense as to why that affected new enrollment numbers. I personally think he thought he would save some $ and slow down, hoping for a halt based on supreme efficacy.

Sadly, there will not be a shortage of trial patients for us, as one model shows the US will go from 12.4 million cases today to almost 20 million cases in just two months! Here in CA, hospitalizations are up over 75% in the last two weeks and ICU rates are up over 50%. I pray these needless deaths are not in vain, and leronlimab can save those projected to get Covid in the coming weeks and months.